Article
100% sustained virological response and fibrosis improvement in real-life use of direct acting antivirals in genotype-1b recurrent hepatitis C following liver transplantation.
Journal of gastrointestinal and liver diseases : JGLD - 1 Jun 2018
Iacob Speranta, Cerban Razvan, Pietrareanu Corina, Ester Carmen, Iacob Razvan, Gheorghe Cristian, Popescu Irinel, Gheorghe Liana
Abstract excerpt
BACKGROUND: Nowadays, interferon-free therapy using new direct-acting antivirals (DAA) has dramatically increased the cure rate across different HCV-infected patient populations, including groups traditionally viewed as difficult-to-treat (patients with co-infections, cirrhosis and liver transplant - LT recipients) with marked improvement in safety and tolerability. AIM: To present our experience with DAA therapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.